e-learning
resources
Vienna 2003
Sunday 28.09.2003
COPD in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people
A. H. Huerta, J. Contreras, G. R. Gartz, M. Gonzalez, A. Rodríguez (Monterrey, Mexico)
Source:
Annual Congress 2003 - COPD in primary care
Session:
COPD in primary care
Session type:
Thematic Poster Session
Number:
539
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. H. Huerta, J. Contreras, G. R. Gartz, M. Gonzalez, A. Rodríguez (Monterrey, Mexico). Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people. Eur Respir J 2003; 22: Suppl. 45, 539
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Reference values for peak flow and FEV1 variation in healthy schoolchildren using home spirometry
Source: Eur Respir J 2008; 32: 1262-1268
Year: 2008
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Individual decline of FEV1 show diversity in COPD
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012
Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR®
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
The prevalence of patients with normal post-bronchodilator spirometry that fulfil the criteria for GOLD mild COPD using ECCS predicted equations
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019
Maximal voluntary ventilation should not be estimated from FEV1 in COPD patients and healthy
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
Changes in FEV
1
over time in COPD and the importance of spirometry reference ranges: the devil is in the detail
Source: Breathe, 15 (4) 337; 10.1183/20734735.0252-2019
Year: 2019
Prospective analysis of lung function in COPD patients – home monitoring of FEV
1
and PEF (PIKO®1)
Source: Eur Respir J 2006; 28: Suppl. 50, 108s
Year: 2006
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Spirometric reference equations for European females and males aged 65-85 yrs
Source: Eur Respir J 2004; 24: 397-405
Year: 2004
Distinguishing hyperinflation from combined restriction in patients with reduced FEV
1
/FVC and FVC on spirometry
Source: Eur Respir J 2006; 28: Suppl. 50, 202s
Year: 2006
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients
Source: Eur Respir J 2003; 21: 21S-27S
Year: 2003
Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD
Source: Eur Respir J 2004; 24: 332
Year: 2004
Annual decline in forced expiratory volume in 1 sec (FEV1) in patients with COPD before and after introduction of tiotropium
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept